NCT00003132View on ClinicalTrials.gov

Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 1998

Primary Completion Date

November 30, 2001

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

bryostatin 1

DRUG

cisplatin

Trial Locations (1)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

NYU Langone Health

OTHER

NCT00003132 - Bryostatin 1 Plus Cisplatin in Treating Patients With Metastatic or Unresectable Cancer | Biotech Hunter | Biotech Hunter